SIGA Technologies Target of Unusually Large Options Trading (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the target of unusually large options trading activity on Wednesday. Stock investors purchased 1,200 call options on the stock. This represents an increase of approximately 1,438% compared to the typical daily volume of 78 call options.

Institutional Trading of SIGA Technologies

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in SIGA Technologies by 28.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 134,382 shares of the company’s stock worth $808,000 after purchasing an additional 29,442 shares during the last quarter. State of Wyoming raised its holdings in SIGA Technologies by 163.5% during the 4th quarter. State of Wyoming now owns 45,668 shares of the company’s stock worth $274,000 after purchasing an additional 28,339 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new stake in SIGA Technologies during the 4th quarter worth about $83,000. ProShare Advisors LLC raised its holdings in SIGA Technologies by 26.6% during the 4th quarter. ProShare Advisors LLC now owns 16,424 shares of the company’s stock worth $99,000 after purchasing an additional 3,455 shares during the last quarter. Finally, Deutsche Bank AG raised its holdings in SIGA Technologies by 53.3% during the 4th quarter. Deutsche Bank AG now owns 41,804 shares of the company’s stock worth $251,000 after purchasing an additional 14,527 shares during the last quarter. 55.40% of the stock is owned by institutional investors.

SIGA Technologies Stock Up 0.7 %

Shares of NASDAQ SIGA opened at $5.47 on Thursday. The firm’s 50-day simple moving average is $6.03 and its 200 day simple moving average is $6.83. The company has a market cap of $390.59 million, a price-to-earnings ratio of 4.56 and a beta of 0.94. SIGA Technologies has a 12-month low of $4.75 and a 12-month high of $12.83.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.